AMOEBA (EPA:ALMIB) | Finanzwire

PRESS RELEASE

published on 08/28/2024 at 17:45, 2 years 2 months ago

AMOEBA prepares for the commercial launch of the AXPERA Product Line in the USA with approval expected by 2025
Amoéba's biofungicide products receive US EPA's admissibility confirmation for registration dossier, accelerating industrial and commercial development. Application for market authorization has been submitted. Collaboration with Dunham Trimmer in progress

AMOEBA Collaboration Market Authorization Biofungicide US EPA
BRIEF

published on 07/02/2024 at 08:35, 2 years 4 months ago

AMOEBA: A NEW LEGAL STRUCTURE TO MAXIMISE COMMERCIAL ACTIVITIES

AMOEBA Biocontrol Cosmetics Legal Reorganisation Subsidiary
REGULATED PRESS RELEASE

published on 07/02/2024 at 08:30, 2 years 4 months ago

AMOEBA: A NEW LEGAL STRUCTURE TO MAXIMISE COMMERCIAL ACTIVITIES
Amoéba announces a reorganisation to enhance commercial activities in biocontrol and cosmetics sectors, aiming to create value for shareholders. New legal structure to optimize resources and facilitate partnerships

AMOEBA Biocontrol Cosmetics Legal Structure Commercial Activities
BRIEF

published on 06/21/2024 at 13:41, 2 years 4 months ago

Edison Issues Report on Amoéba (ALMIB)

AMOEBA Financial Report Edison Investment Research ALMIB
PRESS RELEASE

published on 06/21/2024 at 13:36, 2 years 4 months ago

Edison issues report on Amoéba (ALMIB)
Edison Investment Research Limited issues report on Amoéba (ALMIB) available for download. Not a solicitation to buy or sell securities

AMOEBA Edison Investment Research Limited Financial Analysis Report ALMIB
BRIEF

published on 06/10/2024 at 17:50, 2 years 4 months ago

AMOÉBA Confirms Development Potential in Cosmetics Sector

AMOEBA Clinical Study Cosmetics Skincare INCI List
REGULATED PRESS RELEASE

published on 06/10/2024 at 17:45, 2 years 4 months ago

CONFIRMATION OF THE DEVELOPMENT POTENTIAL OF AMOEBA IN COSMETICS
Amoéba's clinical study confirms the development potential of its cosmetic ingredient for skincare products. Management to present strategy at annual conference in Paris

AMOEBA Clinical Study Cosmetics Paris Conference Skincare Products
BRIEF

published on 05/23/2024 at 18:05, 2 years 5 months ago

AMOEBA: Ordinary and Extraordinary General Meeting Scheduled for June 27, 2024

AMOEBA Shareholders General Meeting Electronic Voting June 2024
REGULATED PRESS RELEASE

published on 05/23/2024 at 18:00, 2 years 5 months ago

AMOEBA: ORDINARY AND EXTRAORDINARY GENERAL MEETING OF 27 JUNE 2024 - Availability of preliminary documents
Amoéba announces Ordinary and Extraordinary General Meeting on June 27, 2024, in Chassieu. Shareholders can access preliminary documents online. Electronic voting available

AMOEBA Shareholders General Meeting Electronic Voting Preliminary Documents
BRIEF

published on 05/06/2024 at 17:50, 2 years 6 months ago

AMOEBA: Declaration of the total number of voting rights and the number of shares making up the capital as of April 30, 2024

AMOEBA Voting Rights Capital Financial Markets Authority April 30, 2024

Published on 11/06/2026 at 22:15, 11 hours 47 minutes ago

Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 21 hours 2 minutes ago

Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 21 hours 32 minutes ago

Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 21 hours 32 minutes ago

Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 10:00, 1 day ago

Mongolia Tax Audit

View all ACCESSWIRE

Published on 11/06/2026 at 20:15, 13 hours 46 minutes ago

African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 19:15, 14 hours 46 minutes ago

EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 15 hours 1 minute ago

Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 18:32, 15 hours 29 minutes ago

EQS-Adhoc: Finexity AG: FINEXITY issues 2026/2030 bond
Published on 11/06/2026 at 18:00, 16 hours 1 minute ago

ARVERNE GROUP: Number shares and voting rights

View all EQS

Published on 11/06/2026 at 18:00, 16 hours 2 minutes ago

ICADE - PR - S&P credit rating
Published on 11/06/2026 at 18:00, 16 hours 2 minutes ago

DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 11/06/2026 at 17:54, 16 hours 7 minutes ago

Disclosure of Share Capital and Voting Rights as of October 31, 2026
Published on 11/06/2026 at 17:35, 16 hours 27 minutes ago

Disclosure of the number of shares and the total number of voting rights as of October 31, 2026
Published on 11/06/2026 at 11:05, 22 hours 56 minutes ago

voting rights

View all LES ECHOS COMFI WIRE

News